can semaglutide damage liver India has approved Novo Nordisk's Wegovy (semaglutide 2.4 mg) for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty disease that lead to inflammation, liver and New analysis of trial of

Patients can expect to see significant weight loss within the first three months of beginning Semaglutide GLP-1 treatment, although individual results may vary

But what if there was a tool that could work with your body to help you achieve your goals

It is important to note that whilst blood test results may normalise relatively quickly, symptom resolution often takes longer

The third generation, built around a single drug called retatrutide, works on three receptors and has just produced 28.7% weight loss in a Phase 3 trial, which is the range that bariatric surgery produces

Do not exceed recommended daily portion

Here is a practical, evidence-based framework for eating on Ozempic, Wegovy, or Mounjaro